🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could result in individuals administering products of uncertain source.

Several experts stated the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, risking penalties, legal action or prison.

Platform Reaction and Content Removal

Based on TikTok, the platform has removed violative content and prohibited associated hashtags and query recommendations. The company said it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.

After minutes of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.

Item Details and Pricing

Inside these communities, messages show black plastic packages with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may subject users to possibly serious medical dangers”.